References
- Charness M, Simon R, Greenberg D. Ethanol and the nervous system. N Engl J Med 1989; 321: 442–54
- Sternbach H. The serotonin syndrome. Am J Psychiatry 1993; 148: 705–13
- Muly EC, McDonald W, Steffens D, Book S. Serotonin syndrome produced by a combination of fluoxetine and lithium. [Letter]. Am J Psychiatry 1993; 150: 1565
- Salzman C, Solomon D, Miyawaki E. Parenteral lorazepam vs. parenteral haloperidol for the control of psychotic disruptive behavior. J Clin Psychiatry 1991; 52: 177–80
- Jefferson JW, Greist JH, Ackerman DL, Carroll JA. Lithium encyclopedia for clinical practice. American Psychiatric Association Press, Washington, DC 1987
- Tyrer S, Shopsin B. Neural and neuromuscular side effects of lithium. Handbook of lithium therapy, FN Johnson. MTP Press, LancasterEngland 1980; 289–309
- Ghadiran AM, Lehmann HE. Acquired transient CNS hypersensitivity to lithium therapy. Can J Psychiatry 1980; 25: 662–5
- Schou M. Lithium. Meyler's side effects of drugs: an encyclopedia of adverse reactions and interactions10th ed., M H G Dukes. Elsevier, Amsterdam 1984; 62–9
- Cohen WJ, Cohen NH. Lithium carbonate, haloperidol and irreversible brain damage. JAMA 1974; 230: 1283–7
- Prakash R, Kelwala S, Ban TA. Neurotoxicity with combined administration of lithium with a neuroleptic. Compr Psychiatry 1982; 23: 657–71
- Ciraulo DA, Shader RI. Fluoxetine drug-drug interactions: I. Antidepressants and antipsychotics. J Clin Psychopharmacol 1990; 10: 48–50
- Goff DC, Midha KK, Brotman AW, Waites M, Baldessarini RJ. Elevation of plasma concentrations of haloperidol after the addition of fluoxetine. Am J Psychiatry 1991; 148: 790–3
- Skjelbo E, Brøsen K. Inhibitors of imipramine metabolism by human liver microsomes. Br J Clin Pharmacol 1992; 34: 256–61
- Salama A, Shafey M. A case of severe lithium toxicity induced by combined fluoxetine and lithium carbonate [Letter]. Am J Psychiatry 1989; 146: 278
- Noveske FG, Hahn KR, Flynn RJ. Possible toxicity of combined fluoxetine and lithium [Letter]. Am J Psychiatry 1989; 146: 1515
- Pato MT, Murphy DL, DeVane CL. Sustained plasma concentrations of fluoxetine and/or norfluoxetine four and eight weeks after fluoxetine discontinuation. J Clin Psychopharmacol 1991; 11: 224–5
- Lock JD, Gwirtsman HE, Targ EF. Possible adverse drug interactions between fluoxetine and other psychotropics. J Clin Psychopharmacol 1990; 10: 383–4